Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

The ATM protein, encoded by the gene responsible for the human genetic disorder ataxia telangiectasia (A-T), regulates several cellular responses to DNA breaks. ATM shares a phosphoinositide 3-kinase–related domain with several proteins, some of them protein kinases. A wortmannin-sensitive protein kinase activity was associated with endogenous or recombinant ATM and was abolished by structural ATM mutations. In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage. This activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug; the total amount of ATM remained unchanged. Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM.

Bibliography

Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., & Ziv, Y. (1998). Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage. Science, 281(5383), 1674–1677.

Authors 11
  1. S. Banin (first)
  2. L. Moyal (additional)
  3. S.-Y. Shieh (additional)
  4. Y. Taya (additional)
  5. C. W. Anderson (additional)
  6. L. Chessa (additional)
  7. N. I. Smorodinsky (additional)
  8. C. Prives (additional)
  9. Y. Reiss (additional)
  10. Y. Shiloh (additional)
  11. Y. Ziv (additional)
References 39 Referenced 1,609
  1. 10.1016/S0092-8674(00)81871-1
  2. 10.1146/annurev.immunol.15.1.177
  3. Shiloh Y., Annu. Rev. Genet. 31, 635 (1997); (10.1146/annurev.genet.31.1.635) / Annu. Rev. Genet. by Shiloh Y. (1997)
  4. ; R. A. Gatti in The Genetic Basis of Human Cancer B. Vogelstein and K. W. Kinzler Eds. (McGraw-Hill New York 1998) pp. 275–300;
  5. 10.1016/S0092-8674(00)80086-0
  6. 10.1101/gad.10.19.2401
  7. Morgan S. E., Kastan M. B., Adv. Cancer Res. 71, 1 (1997). (10.1016/S0065-230X(08)60095-0) / Adv. Cancer Res. by Morgan S. E. (1997)
  8. 10.1126/science.7792600
  9. Savitsky K., et al., Hum. Mol. Genet. 4, 2025 (1995). (10.1093/hmg/4.11.2025) / Hum. Mol. Genet. by Savitsky K. (1995)
  10. Hoekstra M. F., Curr. Opin. Genet. Dev. 7, 170 (1997). (10.1016/S0959-437X(97)80125-6) / Curr. Opin. Genet. Dev. by Hoekstra M. F. (1997)
  11. Hartley K. O., et al., Cell 82, 849 (1995); (10.1016/0092-8674(95)90482-4) / Cell by Hartley K. O. (1995)
  12. Brown E. J., et al., Nature 377, 441 (1995); (10.1038/377441a0) / Nature by Brown E. J. (1995)
  13. Brunn G. J., et al., EMBO J. 15, 5256 (1996); (10.1002/j.1460-2075.1996.tb00911.x) / EMBO J. by Brunn G. J. (1996)
  14. 10.1126/science.277.5322.99
  15. L. Moyal et al. in preparation.
  16. Cells (5 × 10 6 ) were washed in ice-cold phosphate-buffered saline and lysed in 700 μl of 10 mM tris-HCl (pH 7.5) 150 mM NaCl 0.2% dodecyl maltoside (Sigma) 5 mM EDTA 50 mM NaF 2 mM phenylmethylsulfonyl fluoride 100 μM NaVO 4 and aprotinin (lysis buffer) (2 μg/ml). Freshly prepared cell lysates were incubated for 2 hours at 4°C on a rotator with 10 μl of hybridoma supernatants. Magnetic beads coated with antibodies to mouse immunoglobulin G (50 μl; Dynabeads M-450 DYNAL Oslo Norway) were added and the mixture was further rotated at 4°C for 2 hours. Immune complexes were collected using a magnetic stand (DYNAL) and washed three times with lysis buffer. For protein immunoblotting analysis one-third of this mixture was loaded on an SDS-polyacrylamide gel which was later blotted onto a nitrocellulose membrane (Nitrocell MFF Pharmacia) as described (10). Immune complexes were washed twice with kinase buffer [50 mM Hepes (pH 7.5) 150 mM NaCl 4 mM MnCl 2 6 mM MgCl 2 10% (v/v) glycerol 1 mM dithiothreitol and 100 μM NaVO 4 ]. Substrate (200 ng to 1 μg) 10 μCi of γ[ 32 P]adenosine triphosphate (ATP) and ATP to a final concentration of 5 μM were added and the reaction mixtures were incubated at 30°C for 3 to 15 min. After electrophoresis in SDS-polyacrylamide gels the reaction products were visualized by autoradiography.
  17. 10.1126/science.7939721
  18. S. Banin et al. unpublished data.
  19. 10.1038/sj.onc.1201319
  20. Gilad S., et al., Hum. Mol. Genet. 5, 433 (1996). (10.1093/hmg/5.4.433) / Hum. Mol. Genet. by Gilad S. (1996)
  21. Gilad S., et al., Am. J. Hum. Genet. 62, 551 (1998). (10.1086/301755) / Am. J. Hum. Genet. by Gilad S. (1998)
  22. Ui M. T., Okada T., Hazeki K., Hazeki O., Trends Biochem. Sci. 20, 303 (1995); (10.1016/S0968-0004(00)89056-8) / Trends Biochem. Sci. by Ui M. T. (1995)
  23. 10.1128/MCB.16.4.1722
  24. 10.1101/gad.11.24.3471
  25. 10.1016/S0092-8674(00)80416-X
  26. Watters D., et al., Oncogene 14, 1911 (1997). (10.1038/sj.onc.1201037) / Oncogene by Watters D. (1997)
  27. Kitagawa M., et al., EMBO J. 15, 7060 (1996); (10.1002/j.1460-2075.1996.tb01097.x) / EMBO J. by Kitagawa M. (1996)
  28. Ko L. J., et al., Mol. Cell. Biol. 17, 7220 (1997). (10.1128/MCB.17.12.7220) / Mol. Cell. Biol. by Ko L. J. (1997)
  29. Lakin N. D., et al., Oncogene 13, 2707 (1996); / Oncogene by Lakin N. D. (1996)
  30. Brown K. D., et al., Proc. Natl. Acad. Sci. U.S.A. 94, 1840 (1997). (10.1073/pnas.94.5.1840) / Proc. Natl. Acad. Sci. U.S.A. by Brown K. D. (1997)
  31. I. H. Goldberg and L. S. Kappen in Enediyne Antibiotics as Antitumor Agents D. B. Borders and T. W. Doyle Eds. (Dekker New York 1995) pp. 327–362.
  32. Keegan K. S., et al., Genes Dev. 10, 2423 (1996); (10.1101/gad.10.19.2423) / Genes Dev. by Keegan K. S. (1996)
  33. Jung M., et al., Cancer Res. 57, 24 (1997). / Cancer Res. by Jung M. (1997)
  34. Fiscella M., et al., Oncogene 8, 1519 (1993). / Oncogene by Fiscella M. (1993)
  35. 10.1016/0092-8674(92)90644-R
  36. Oliner J. D., et al., Nature 362, 857 (1993). (10.1038/362857a0) / Nature by Oliner J. D. (1993)
  37. Haupt Y., Maya R., Kazaz A., Oren M., Nature 387, 286 (1997); (10.1038/387296a0) / Nature by Haupt Y. (1997)
  38. ; M. H. G. Kubbutat S. N. Jones K. H. Vousden ibid. p. 299.
  39. We thank M. Hoekstra for the cell line G361; J. Ahn for p53-derived constructs; E. Lee R. Nechushtai G. Rathbun and B. Price for useful advice; and F. Zetland for manuscript editing. Supported by the A-T Medical Research Foundation the A-T Children's Project NIH grant NS31763 the Thomas Appeal (A-T Medical Research Trust) the A-T Appeal and a fellowship of the Council for Higher Education of the State of Israel (S.B.).
Dates
Type When
Created 23 years, 1 month ago (July 27, 2002, 5:43 a.m.)
Deposited 1 year, 7 months ago (Jan. 12, 2024, 10:25 p.m.)
Indexed 3 days, 11 hours ago (Aug. 26, 2025, 2:50 a.m.)
Issued 26 years, 11 months ago (Sept. 11, 1998)
Published 26 years, 11 months ago (Sept. 11, 1998)
Published Print 26 years, 11 months ago (Sept. 11, 1998)
Funders 0

None

@article{Banin_1998, title={Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage}, volume={281}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.281.5383.1674}, DOI={10.1126/science.281.5383.1674}, number={5383}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Banin, S. and Moyal, L. and Shieh, S.-Y. and Taya, Y. and Anderson, C. W. and Chessa, L. and Smorodinsky, N. I. and Prives, C. and Reiss, Y. and Shiloh, Y. and Ziv, Y.}, year={1998}, month=sep, pages={1674–1677} }